Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by coinmanon Mar 30, 2020 8:07pm
135 Views
Post# 30862321

QUESTCAP APPOINTS NEW CEO, OUTLINES NEW INVESTMENT STRATEGY

QUESTCAP APPOINTS NEW CEO, OUTLINES NEW INVESTMENT STRATEGY

QUESTCAP APPOINTS NEW CEO, OUTLINES NEW INVESTMENT STRATEGY AND PROVIDES CORPORATE UPDATE

TORONTO, March 30, 2020 (GLOBE NEWSWIRE) --

QuestCap Inc. (“QuestCap” or the “Company”) (CSE: QSC; OTCMKTS: COPRF; FRA: 34C1) is pleased to announce its new investment strategy for the Company and the appointment of a new CEO to drive the strategy forward. The Company has outlined three new strategic directions for its investment strategy: MedQuest, ClimateQuest, and TechQuest. These divisions will focus on investments in public health, mitigating climate change and innovative technologies, respectively. Together they aim to improve the world and humankind through highly targeted social-impact investing.

QuestCap Appoints Neil Said as Chief Executive Officer

Neil Said is a businessman and corporate securities lawyer who has worked as an officer and legal consultant to numerous Canadian listed companies in the technology, cannabis, mining, oil & gas and healthcare industries. Mr. Said began his career as a securities lawyer at Osler, Hoskin & Harcourt LLP, where he worked on a variety of corporate and commercial transactions. Neil is also currently the head of legal for the Forbes & Manhattan group of companies. Mr. Said obtained a Juris Doctor from the Faculty of Law at the University of Toronto and he received a Bachelor of Business Administration (Honours) with a minor in Economics from Wilfrid Laurier University.

The appointment of Mr. Said follows the resignation of Mr. Stan Bharti as Chief Executive Officer of QuestCap. Mr. Bharti will continue as a director and, along with Scott Moore, will act as Co-Chairman of the Company.

New Investment Strategy

MedQuest
The Covid-19 pandemic is threatening societies across the world. This virus has created serious challenges but also new opportunities to bring life-saving technology and therapies to market. MedQuest is pursuing numerous investments in health sciences to help advance and develop products used to detect, treat, and overcome COVID-19. MedQuest is looking to invest in opportunities that will: improve testing around the world, source effective therapies, and develop a lasting cure.

ClimateQuest
Anthropogenic climate change is threatening to drastically alter the environments we inhabit and the way we live. In order to prevent further degradation of our planet, it is imperative that mankind adopt new technologies and systems that limit, eliminate, or removed greenhouse gas emissions. The crisis is understood and numerous organizations and entrepreneurs have produced powerful innovations but lack the resources to commercialize them. Enter ClimateQuest. Our experienced team will source, review and identify meaningful investment opportunities in sustainable initiatives that have the potential to produce tangible environmental impacts.

TechQuest
Disruptive innovation changed transportation from horseback to cars, communication from landlines to cellphones, and entertainment from cable to streaming video. TechQuest aims to continue human evolution by sourcing and financing groundbreaking technology, procedures, and platforms. We will work with innovators and developers to fund their passions and help turn them into reality. Partnering with visionaries at the seed-stage has the potential to create exceptional value for TechQuest investors.

Eco Capital Acquisition

Finally, further to the Company’s press release dated March 23, 2020, QuestCap announces the signing of the definitive agreement with respect to, and the completion of, the acquisition (the “Acquisition”) of all of the issued and outstanding common shares in the capital of Eco Capital Growth Corp., a British Colombia company (“Eco Capital”). In consideration for the Acquisition, QuestCap issued 8,000,000 common shares of the Company at a deemed price of $0.07 per share in exchange for all of the common shares in the capital of Eco Capital, resulting in the shareholders of Eco Capital owning 12.6% of the Company on an undiluted basis.

Engagement of Native Ads and Hybrid Financial

Additionally, the Company has entered into a 12-month programmatic digital advertising campaign with Native Ads for a total cost of US$700,000, comprised of $525,000 for digital advertising, paid distribution, and media buying over the campaign period and, $175,000 for content creation, consulting, managed services and management fees over the course of the campaign period. Native Ads is a full-service ad agency, that owns and operates a proprietary ad exchange with over 80 integrated SSPs (supply-side platforms) resulting in access to 3-7 billion daily North American ad impressions. Neither Native Ads nor any of its directors and officers own any securities of the Company.

Hybrid Financial has been engaged by QuestCap for a period of six-months starting April 1, 2020 which term may be renewed for successive three-month periods thereafter upon the mutual agreement of QuestCap and Hybrid. Hybrid will be paid a monthly fee of $66,666.67, plus applicable taxes, during the initial six-month term. Hybrid is a sales and distribution company that actively connects issuers to the investment community across North America. Using a data driven approach, Hybrid provides its clients with comprehensive coverage of both American and Canadian markets. Hybrid Financial has offices in Toronto and Montreal.

About Eco Capital

Eco Capital is a uniquely positioned early stage investor, developer and incubator of sustainably focused high growth opportunities with a focus on financial return, lasting positive environmental impact and benefiting society.

About QuestCap

QuestCap is an investment company that seeks to enhance shareholder value over the long term by opportunistically making various investments that may include, without limitation, the acquisition of equity, debt or other securities of publicly traded or private companies or other entities, financing in exchange for pre-determined royalties or distributions and the acquisition of all or part of one or more businesses, portfolios or other assets.

For additional information, please contact:

Scott Moore
Co-Chairman
smoore@forbesmanhattan.com
1-416-861-5903


<< Previous
Bullboard Posts
Next >>